{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:01:27Z","timestamp":1791223287310,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ncl.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T19:52:53Z","timestamp":1633031573000},"page":"1083-1096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Electrodiagnostic Assessment of Hyperexcitable Nerve Disorders"],"prefix":"10.1016","volume":"39","author":[{"given":"Spencer K.","family":"Hutto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor B.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncl.2021.06.009_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.880170106","article-title":"Idiopathic generalized myokymia","volume":"17","author":"Jamieson","year":"1994","journal-title":"Muscle Nerve"},{"issue":"Pt 8","key":"10.1016\/j.ncl.2021.06.009_bib2","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2021.06.009_bib3","first-page":"173","article-title":"De la choree bibrillaire per de Dr Morvan de Lannills","volume":"27","author":"Morvan","year":"1890","journal-title":"Gaz Hebdomadaire de Med de Chirurgie"},{"issue":"4","key":"10.1016\/j.ncl.2021.06.009_bib4","first-page":"257","article-title":"[What is left of Morvan's fibrillary chorea?]","volume":"150","author":"Serratrice","year":"1994","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"10.1016\/j.ncl.2021.06.009_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.24.4.319","article-title":"A\u00a0syndrome of continuous muscle-fibre activity","volume":"24","author":"Isaacs","year":"1961","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ncl.2021.06.009_bib6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1212\/WNL.41.7.1021","article-title":"Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder","volume":"41","author":"Tahmoush","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2021.06.009_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.24632","article-title":"Isaacs syndrome: a review","volume":"52","author":"Ahmed","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2021.06.009_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/brain\/61.3.311","article-title":"Fibrillation and fasciculations in voluntary muscle","volume":"61","author":"Denny-Brown","year":"1938","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ncl.2021.06.009_bib9","first-page":"138","article-title":"Myokymia and neuromyotonia 2004","volume":"251","author":"Gutmann","year":"2004","journal-title":"J\u00a0Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2021.06.009_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/mus.880171102","article-title":"The origin of muscle fasciculations and cramps","volume":"17","author":"Layzer","year":"1994","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ncl.2021.06.009_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mus.20341","article-title":"Muscle cramps","volume":"32","author":"Miller","year":"2005","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ncl.2021.06.009_bib12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.clinph.2020.03.014","article-title":"AANEM - IFCN glossary of terms in neuromuscular electrodiagnostic medicine and ultrasound","volume":"131","author":"Dengler","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2021.06.009_bib13","first-page":"88","article-title":"Myokymia and the benighn fasciculation of muscular cramps","volume":"61","author":"Denny-Brown","year":"1948","journal-title":"Trans Assoc Am Physic"},{"issue":"11","key":"10.1016\/j.ncl.2021.06.009_bib14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/mus.880171103","article-title":"AAEM minimonograph #44: diseases associated with excess motor unit activity","volume":"17","author":"Auger","year":"1994","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ncl.2021.06.009_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mus.880141102","article-title":"AAEM minimonograph #37: facial and limb myokymia","volume":"14","author":"Gutmann","year":"1991","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ncl.2021.06.009_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1212\/CON.0000000000000520","article-title":"Peripheral Nerve Hyperexcitability Syndromes","volume":"23","author":"Sawlani","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"issue":"17","key":"10.1016\/j.ncl.2021.06.009_bib17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF01712058","article-title":"[Neuromyotonia]","volume":"43","author":"Mertens","year":"1965","journal-title":"Klin Wochenschr"},{"issue":"2","key":"10.1016\/j.ncl.2021.06.009_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1097-4598(200102)24:2<151::AID-MUS10>3.0.CO;2-7","article-title":"When is myokymia neuromyotonia?","volume":"24","author":"Gutmann","year":"2001","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ncl.2021.06.009_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"Josephs","year":"2004","journal-title":"J\u00a0Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2021.06.009_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cnp.2017.02.002","article-title":"Afterdischarges following M waves in patients with voltage-gated potassium channels antibodies","volume":"2","author":"Niu","year":"2017","journal-title":"Clin Neurophysiol Pract"},{"issue":"2","key":"10.1016\/j.ncl.2021.06.009_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.0b013e3182061b1e","article-title":"Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients","volume":"76","author":"Rubio-Agusti","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2021.06.009_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mus.20536","article-title":"Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability","volume":"33","author":"Maddison","year":"2006","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2021.06.009_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.410150104","article-title":"Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness","volume":"15","author":"Auger","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2021.06.009_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/jns.12422","article-title":"Utility of stimulus induced after discharges in the evaluation of peripheral nerve hyperexcitability: old wine in a new bottle?","volume":"26","author":"Nair","year":"2021","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"10.1016\/j.ncl.2021.06.009_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/mus.20774","article-title":"Accuracy of repetitive nerve stimulation for diagnosis of the cramp-fasciculation syndrome","volume":"35","author":"Harrison","year":"2007","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2021.06.009_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2004.03.025","article-title":"Repetitive nerve stimulation for the evaluation of peripheral nerve hyperexcitability","volume":"221","author":"Benatar","year":"2004","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.ncl.2021.06.009_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/WNP.0b013e3181968f00","article-title":"Defining normal duration for afterdischarges with repetitive nerve stimulation: a pilot study","volume":"26","author":"Bodkin","year":"2009","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.ncl.2021.06.009_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.23935","article-title":"Cramp-fasciculation syndrome in patients with and without neural autoantibodies","volume":"49","author":"Liewluck","year":"2014","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.ncl.2021.06.009_bib29","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1212\/WNL.42.9.1845-d","article-title":"Cramp-fasciculation syndrome","volume":"42","author":"Verdru","year":"1992","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2021.06.009_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mus.10266","article-title":"Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability","volume":"26","author":"Vernino","year":"2002","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ncl.2021.06.009_bib31","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.53.6.1233","article-title":"Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability","volume":"53","author":"Vernino","year":"1999","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2021.06.009_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11940-018-0510-9","article-title":"Current treatment options for peripheral nerve hyperexcitability syndromes","volume":"20","author":"Elangovan","year":"2018","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ncl.2021.06.009_bib33","first-page":"317","article-title":"New insights into the pathogenesis and therapeutics of episodic ataxia type 1","volume":"9","author":"D'Adamo","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.ncl.2021.06.009_bib34","first-page":"868","article-title":"Axonal neuropathy with neuromyotonia: there is a HINT","volume":"140","author":"Peeters","year":"2017","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ncl.2021.06.009_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/revneuro-2014-0066","article-title":"Peripheral nerve hyperexcitability syndromes","volume":"26","author":"Kucukali","year":"2015","journal-title":"Rev Neurosci"},{"issue":"Pt 2","key":"10.1016\/j.ncl.2021.06.009_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/brain\/116.2.453","article-title":"Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review","volume":"116","author":"Newsom-Davis","year":"1993","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ncl.2021.06.009_bib37","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ncl.2021.06.009_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nrl.2013.12.007","article-title":"Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex","volume":"30","author":"Montojo","year":"2015","journal-title":"Neurologia"},{"key":"10.1016\/j.ncl.2021.06.009_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","article-title":"Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes","volume":"133","author":"Irani","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"Pt 5","key":"10.1016\/j.ncl.2021.06.009_bib40","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ncl.2021.06.009_bib41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.20221","article-title":"Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia","volume":"56","author":"Tomimitsu","year":"2004","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2021.06.009_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2021.06.009_bib43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaneurol.2018.2681","article-title":"Association of leucine-rich glioma inactivated Protein 1, contactin-associated Protein 2, and Contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia","volume":"75","author":"Vincent","year":"2018","journal-title":"JAMA Neurol"},{"issue":"Pt 3","key":"10.1016\/j.ncl.2021.06.009_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/brain\/awl003","article-title":"Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies","volume":"129","author":"Cortelli","year":"2006","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2021.06.009_bib45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/WNP.0000000000000291","article-title":"Therapeutic implications of peripheral nerve hyperexcitability in muscle cramping: a retrospective review","volume":"33","author":"Hurst","year":"2016","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.ncl.2021.06.009_bib46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0036-1585453","article-title":"Autoantibody-associated central nervous system neurologic disorders","volume":"36","author":"Linnoila","year":"2016","journal-title":"Semin Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2021.06.009_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.ncl.2021.06.009_bib48","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2021.06.009_bib49","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2010.03.024","article-title":"Management of voltage-gated potassium channel antibody disorders","volume":"28","author":"Merchut","year":"2010","journal-title":"Neurol Clin"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:21:10Z","timestamp":1760005270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861921000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0733861921000682"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.06.009","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrodiagnostic Assessment of Hyperexcitable Nerve Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}